Determinants of adherence to sirolimus among lymphangioleiomyomatosis patients
Abstract Background Lymphangioleiomyomatosis (LAM) is a low-grade malignant neoplasm characterized by multisystem involvement. Patients with LAM require long-term sirolimus therapy to slow disease progression, yet poor adherence to this medication may lead to reduced lung function and disease deteri...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-02-01
|
| Col·lecció: | BMC Pulmonary Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12890-026-04157-7 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|